GCPL has undergone a significant leadership transition with MD & CEO Sudhir Sitapati resigning effective August 11, 2026, marking the end of the company's GCPL 3.0 phase. The board had approved his reappointment for another five years on May 7, 2026, and shareholders approved it at the AGM on August 7, making his exit particularly surprising. Nomura described Sitapati's stepping down as a shock, noting that under his leadership, GCPL underwent material transformation in strategy, operations and team. Sitapati highlighted four key achievements in his resignation letter: GCPL's share price return of 10% versus 8% for the Nifty FMCG Index, 97% of analysts having Buy or Hold ratings, accelerating growth as India emerges from a difficult FMCG period, and completing his set objectives. The board agreed to the change since his successor was already in place and the company preferred an internal candidate with no transition period needed.
Aasif Malbari, currently Global CFO and President – Godrej Africa, has been appointed as the new MD & CEO effective August 10, 2026. Malbari brings three decades of experience in FMCG and auto industries, including stints at GCPL, Tata Motors and Hindustan Unilever. As global CFO, he directly oversaw business strategy and played a critical role in partnering leadership teams across geographies. Nomura expects business continuity to be maintained under Malbari, with FY27 guidance unchanged and no sudden changes likely. Malbari's focus areas include getting soaps and liquid vaporizers back to profitable growth, harvesting GCPL's strong R&D capabilities better, tapping into Q-comm more and moving faster with Muuchstac, increasing execution pace, and growing perfumes organically. The brokerage highlighted his transformation of GCPL's Africa business, where EBITDA margins improved from 9% in FY24 to 15% in FY26.
Nomura has retained its 'Buy' rating on GCPL but lowered its target price to ₹1,110 from ₹1,300, citing uncertainty around the leadership transition. The brokerage has reduced its EV/EBITDA multiple to 28.5 times from 33 times, a 15% discount to its 10-year average given the uncertainty. Multiple brokerages continue to maintain bullish stances with buy ratings and target prices of ₹1,300, reflecting strong confidence in the company's operational performance and strategic initiatives. ICICI Securities has upgraded its recommendation with a buy rating and target price of ₹1,300, representing a significant increase from previous targets. Motilal Oswal has also recommended a buy rating with a target price of ₹1,300 in its research report dated August 11, 2026, citing the company's strong fundamentals and growth prospects. This upgrade comes alongside HDFC Securities' existing buy rating with a ₹1,250 target, indicating broad market consensus on the stock's potential.
Godrej Consumer's Q1FY27 performance was volume-led with consolidated sales up approximately 18% year-on-year, demonstrating strong operational momentum across key segments. The company achieved underlying volume growth (UVG) of 9%, with India sales growing 11% YoY despite challenges in household insecticides (HI) demand and input-led supply issues. Home Care and Personal Care segments rose 12% and 11% respectively, while GAUM (Gulf, Africa, US, Middle East) remained a key positive with 25% constant-currency growth. Speedboats scaled to approximately 17% of standalone sales, up from 14% in Q1FY26, indicating successful strategic initiatives. During recent earnings calls, the company maintained its FY27 guidance of high-single-digit volume growth, double-digit revenue growth, and double-digit profit growth, demonstrating confidence in sustained performance.
The company faced margin pressure mainly from inflation in LPG, kerosene and LABSA, but the correction in LPG to approximately ₹90/kg from ₹190/kg could aid recovery in H2FY27. Management expects Indian margins to recover in the second half as costs stabilize. Despite these headwinds, the company demonstrated resilience with margin recovery expected to be supported by the LPG price correction and improved operational efficiency. The overseas business continues to fire on all cylinders with 30% overall growth, with Africa, US & Middle East business up 47% and Indonesia showing continued recovery. The company's key objective has been enhancing volume growth to double digits (9% achieved in Q1), turning around GAUM (achieved), and decisively turning around in HI in India.
